These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. High-dose intravenous immune globulin in the management of severe Guillain-Barre syndrome. Baskin E; Turkay S; Icagasioglu D; Tanzer F; Cevit O Turk J Pediatr; 1996; 38(1):119-23. PubMed ID: 8819632 [TBL] [Abstract][Full Text] [Related]
4. Rapid recovery of a child with Guillain-Barré syndrome using intravenous immunoglobulins. Shah M; Weinberger M J La State Med Soc; 1998 Nov; 150(11):533-7. PubMed ID: 9861805 [TBL] [Abstract][Full Text] [Related]
6. Guillain-Barré syndrome. Pemberton L Nurs Times; 1998 Nov 18-24; 94(46):50-3. PubMed ID: 9923382 [No Abstract] [Full Text] [Related]
7. Severe Guillain-Barré syndrome associated with Campylobacter jejuni infection with failure to respond to plasmapheresis and immunoglobulin. Allen A; Antony SJ J Am Board Fam Pract; 1999; 12(3):249-52. PubMed ID: 10395423 [No Abstract] [Full Text] [Related]
8. [Treatment of Guillain-barre syndrome: immunoglobulins or plasmapheresis?]. Martínez Yélamos A; Huerta Villanueva M; Olivé Plana M; Montero Homs J; Serra Catafau J; Martínez-Matos JA Neurologia; 1998 Apr; 13(4):166-9. PubMed ID: 9608755 [TBL] [Abstract][Full Text] [Related]
9. [Guillain-Barré syndrome in children treated with intravenous immunoglobulin]. Andersen UM Ugeskr Laeger; 1993 Oct; 155(42):3392-4. PubMed ID: 8259633 [TBL] [Abstract][Full Text] [Related]
10. Natural history and treatment effects in Guillain-Barré syndrome: a multicentre study. Korinthenberg R; Mönting JS Arch Dis Child; 1996 Apr; 74(4):281-7. PubMed ID: 8669925 [TBL] [Abstract][Full Text] [Related]
11. [Guillain-Barré disease: a current treatment method using immunoglobulins]. Kleyweg RP; van der Meché FG Ned Tijdschr Geneeskd; 1992 Oct; 136(40):1956-60. PubMed ID: 1328903 [No Abstract] [Full Text] [Related]
12. [Use of intravenous immunoglobulins in Guillain-Barré syndrome]. Ceccarelli M; Assanta N; Chiaravalloti G; Rocopou C; Caiulo VA Minerva Pediatr; 1992 May; 44(5):237-40. PubMed ID: 1620076 [TBL] [Abstract][Full Text] [Related]
14. Guillain-Barré syndrome in mother and newborn child. Luijckx GJ; Vles J; de Baets M; Buchwald B; Troost J Lancet; 1997 Jan; 349(9044):27. PubMed ID: 8988121 [No Abstract] [Full Text] [Related]
15. Intravenous IgG in Guillain-Barré syndrome. Hughes RA BMJ; 1996 Aug; 313(7054):376-7. PubMed ID: 8761208 [No Abstract] [Full Text] [Related]
16. Single-dose intravenous immune globulin for treatment of Guillain-Barré syndrome. McGhee B; Jarjour IT Am J Hosp Pharm; 1994 Jan; 51(1):97-9. PubMed ID: 8135270 [No Abstract] [Full Text] [Related]
17. 'Immunoglobulin therapy in Guillain-Barré syndrome in children'. Ganesan V; Kirkham FJ Dev Med Child Neurol; 1996 Apr; 38(4):371-2. PubMed ID: 8641543 [No Abstract] [Full Text] [Related]
18. [Plasmapheresis and high-dose immunoglobulins in the treatment of acute demyelinating polyneuropathy]. Marino A; Logi G; Roncucci P; Sodini ML; Fornaini F Minerva Anestesiol; 1993 Jun; 59(6):307-11. PubMed ID: 8414090 [TBL] [Abstract][Full Text] [Related]
19. Immunoglobulins in the treatment of Guillain-Barré syndrome in early childhood. al-Qudah AA J Child Neurol; 1994 Apr; 9(2):178-80. PubMed ID: 8006371 [TBL] [Abstract][Full Text] [Related]
20. Intravenous immunoglobulin treatment in children with Guillain-Barre syndrome. Gürses N; Uysal S; Cetinkaya F; Işlek I; Kalayci AG Scand J Infect Dis; 1995; 27(3):241-3. PubMed ID: 8539548 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]